Alchemab Therapeutics, whose labs are in Cambridge UK, stands to scoop $415 million from Eli Lilly and Company following a ...

The appointment May 6 of Vinay Prasad as the head of the U.S. FDA’s Center for Biologics Evaluations and Research sent ripples across the industry. Shares of Sarepta Therapeutics Inc. (NASDAQ:SRPT) ...